Picture of ChemoMetec A/S logo

CHEMM ChemoMetec A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: Chemometec Says Full-Year Guidance Maintained

Feb 5 (Reuters) - Chemometec A/S  CHEMM.CO :
    * INTERIM REPORT 2023/24 - FULL-YEAR GUIDANCE MAINTAINED
DESPITE
CONTINUED CHALLENGING MARKET CONDITIONS
    * REVENUE WAS DOWN 15% IN Q2 OF 2023/24 TO DKK 108.1 MILLION
FROM
DKK 126.8 MILLION IN YEAR-EARLIER PERIOD
    * EBITDA FOR Q2 FELL BY 36% TO DKK 93.1 MILLION, AND EBITDA
MARGIN
WAS 48%, COMPARED WITH 63% IN YEAR-EARLIER PERIOD

Source text for Eikon:  ID:nGNEbq3WYD 
Further company coverage:  CHEMM.CO 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on ChemoMetec A/S

See all news